1-1, Doshomachi 4-chome, Chuo-ku,
Osaka,
540-8645
Japan,
+81-6-6204-2111
www.takeda.com
Takeda Pharmaceutical Company Limited is a Japan-based company engaged in the pharmaceutical business. Research & Development, Manufacturing, Sales and Marketing, and Import/Export of Pharmaceutical Drugs, etc.The Company operates in three business segments,Ethical, Healthcare and others.
| Year | ≤ '13 | '14 | '15 | '16 | '17 | '18 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.6/yr) | # | 8 | - | - | 1 | 1 | 1 | 11 |
| vol | $20.0B | $5.2B | $67.7B | $93.0B | ||||
| Sell (0.2/yr) | # | - | - | 1 | - | - | - | 1 |
| vol | $575M | $575M | ||||||
| 12 | ||||||||
| Financial | Deals |
|---|---|
|
Sign-up to View
|
1 |
|
Sign-up to View
|
1 |
|
Sign-up to View
|
1 |
| Legal | Deals |
|---|---|
|
Sign-up to View
|
1 |
|
Sign-up to View
|
1 |
|
Sign-up to View
|
1 |
| Buy | # | TOTAL |
|---|---|---|
| > $1B | Sign-up to View | |
| $100M to $1B | Sign-up to View | |
| < $100M | Sign-up to View | |
| TOTAL | Sign-up to View | |
| Largest |
Shire plc $67.7B (2018-05-08) |
|
| Sell | # | Total |
|---|---|---|
| > $1B | Sign-up to View | |
| $100M to $1B | Sign-up to View | |
| < $100M | Sign-up to View | |
| Total | Sign-up to View | |
| Largest |
Takeda Pharmaceutical Company - Core Respiratory Business $575M (2015-12-16) |
|
According to our data here at Mergr, Takeda Pharmaceutical has acquired 15 companies, including 3 in the last 5 years. A total of 6 acquisitions came from private equity firms. It has also divested 1 asset.
Takeda Pharmaceutical’s largest acquisition to date was in 2018, when it acquired Shire for $67.7B. It’s largest disclosed sale occurred in 2015, when it sold Takeda Pharmaceutical Company - Core Respiratory Business to AstraZeneca for $575M. Takeda Pharmaceutical has acquired in 6 different US states, and 4 countries. The Company’s most targeted sectors include life science (91%) and healthcare services (10%).
When analyzing the healthcare services sector as a whole, according to Mergr, in the last 3 years, there are 415 healthcare services companies that have made at least 1 acquisition, 35 have acquired at least 5 companies, and 6 have acquired more than 10 companies. The most prolific strategic healthcare services acquirer over the past 3 years is MEDNAX, with 26 acquisitions. The most prolific private equity acquirer in the healthcare services sector over the past 3 years is Nordic Capital with 7 platform acquisitions.
Join Mergr and gain access to Takeda Pharmaceutical’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the healthcare services sector.
No obligation. Cancel anytime.
